ID
CC icon

Integral Derivatives’s Chemours CC Stock Holding History

Integral Derivatives’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-21,000
Closed -$1.05M – 712
2017
Q4 		$1.05M Buy
21,000
+4,500
+27% +$236K 0.02% 466
2017
Q3 		$835K Sell
16,500
-1,600
-9% -$75.5K 0.02% 559
2017
Q2 		$686K Sell
18,100
-24,400
-57% -$962K 0.01% 604
2017
Q1 		$1.64M Buy
42,500
+12,360
+41% +$372K 0.03% 366
2016
Q4 		$666K Buy
+30,140
New +$619K 0.01% 629

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Integral Derivatives's CC Position: Q1 2016 in Review

Integral Derivatives sold out of Chemours (CC) in Q1 2016, closing a stake of 14,888 shares — an estimated $74.8K sold.

Integral Derivatives first reported a position in CC in Q3 2015 and held it in 2 quarters. The position peaked at $80K in Q4 2015. 415 funds tracked by Wall St. Rank hold CC as of Q1 2016.

  • Integral Derivatives reported no remaining Chemours position as of Q1 2016 after selling out during the quarter.
  • Integral Derivatives sold 14,888 Chemours shares in Q1 2016, an estimated $74.8K.
  • Integral Derivatives first reported a position in Chemours in Q3 2015 and held it in 2 quarters.
  • Integral Derivatives's Chemours position peaked at $80K in Q4 2015.
  • 415 funds tracked by Wall St. Rank held Chemours as of Q1 2016.

Based on Integral Derivatives's 13F filing for Q1 2016, filed 12 Apr 2016.